Introduction
Pasteurella multocida is implicated as an aetiological agent in progressive atrophic rhinitis (PAR) in pigs and is commonly isolated from the lungs of pigs with enzootic pneumonia. The progressive degeneration of nasal turbinate tissue seen in PAR is predominantly associated with toxigenic strains of fl multocida [ 1-31. Hybridisation studies have demonstrated that toxigenic strains of J? multocida (of capsular types A and D) contain a chromosomally located toxA gene, whilst nontoxigenic strains do not [4] . Toxigenic strains reproduce the clinical symptoms of PAR when experimentally inoculated into pigs [ 5 ] and express a 145-kDa dermonecrotic toxin (DNT). This toxin is lethal for mice [l] , induces osteolysis in swine turbinate bones and produces haemorrhagic and necrotic lesions in guinea-pig skin [6] . Toxigenic strains demonstrate invitro toxigenicity for tissue culture cell lines, including embryonic lung and Vero cells, and such assays are used as diagnostic tools [7, 81 . Furthermore, a recombinant toxin derivative with a deletion of 121 amino acids in the N-terminal region of the native DNT [9] has been shown to be non-toxigenic and protective as a vaccine against PAR in gilts challenged intranasally with Bordetella bronchiseptica and I? multocida [ lo] .
Five capsular types (A, B, C, D and E) are recognised within the genus Pasteurella, with types A and D most frequently isolated from the respiratory tract of pigs [ 1 11. Although both toxigenic and non-toxigenic varieties of capsular types A and D have been described, toxigenic isolates from pigs with PAR in Australia are almost exclusively capsular type D [2] whilst I? multocida isolates from pneumonic lesions are typically non-toxigenic, capsular type A [3, . Two field surveys conducted in New South Wales (NSW), Australia, during 1989 Australia, during -1990 revealed that lung isolates of I? multocida are widespread across different herds with a strong association between lesion severity and frequency of isolation of the organism [3] . Nontoxigenic, capsular type A isolates of Z? multocida have also been associated with severe pleuritis in two North American herds, where grower and finisher pigs showed severe emaciation and a high mortality rate [ multocida and digested with Cfo I. Restriction endonuclease profiles, resolved by polyacrylamide gel electrophoresis and visualised by silver staining, were compared. Twelve of the 22 isolates were from the nasal passages of pigs with clinical symptoms of PAR whilst the remaining 10 isolates were from pneumonic lung lesions during sporadic outbreaks of pneumonia in geographically diverse Australian herds. The capsular type of these strains was determined and the presence of the toxA gene was confirmed by Southern hybridisation and PCR. In addition, toxin production in each of these isolates was assessed by a cytotoxin assay.
Materials and methods

Culture of 19 multocida
Strains of I? multocida used in this study are listed in Table 1 . The geographic location of all 22 isolates is depicted in Fig. 1 . Z? multocida isolates 7, 10 and 11 were from pneumonic lung lesions from pigs and were stored as freeze-dried ampoules during 1969-1970. Records identifying the sources of these strains are no longer available. However, these isolates were cultured from lungs by the Regional Veterinary Laboratory at Glenfield which serviced the Hunter, central and far west, southern tablelands and south coast of NSW as well as the metropolitan region of Sydney. All lung isolates were from samples obtained from pigs at necropsy and cultured on blood agar (sterile sheep blood agar 10% v/v; Columbia agar base 3.85% w/v; granulated agar 0.73% w/v). Twelve isolates were from nasal swabs of the turbinates of pigs with clinical signs of PAR cultured on selective blood agar [2] . From lyophilised stocks of these isolates, subcultures were grown on blood agar incubated overnight at 37°C in C02 5% v/v in air. From these plates, brain heart infusion broth (BHIB) 3.7% was inoculated with a single colony of I? multocida and shaken (200 oscillations/min) for 4-6 h until mid-log phase. I? multocida was harvested by centrifugation (1 0 000 rpm, 15 min; Sorvall SS34 head) and washed twice with sterile TBS (10 mM Tris-HC1, pH 7.4; NaCl 0.9%).
Phenotypic characteristics
All I? multocida isolates were stained by Gram's method [23] . The identity of bacterial isolates was confirmed by standard biochemical tests [24] .
Capsular typing of 19 multocida isolates
Z? multocida isolates were classed as capsular type A or D by the acriflavine and hyaluronidase test, respectively [2] . Briefly, one drop of freshly prepared acriflavine solution (diluted 1 in 1000 with milliQ water; Sigma) was mixed with a colony of bacteria taken from an overnight blood-agar culture. Type D bacteria, but not type A, produce a coarse flocculent precipitate within 30 min at room temperature. The hyaluronidase test was performed by first impregnating 5 X 30 mm sterile Whatman filter strips in a sterile solution of ovine testicular hyaluronidase (700 U/ml; Sigma). These strips were then laid across blood agar plates pre-streaked with each I? multocida isolate. After incubation at 37°C in C02 5%, the continuity of growth was assessed. Growth of type A but not type D cultures was inhibited in the immediate vicinity of the hyaluronidase strip.
Toxin tests
A cellular cytotoxicity assay [2] was used to determine the production of toxins by isolates of I? multocida. Briefly, bovine turbinate cells (BTC) were cultured in 0.5 ml of basal medium Eagle (modified) with Hanks's salt (BME/H) containing fetal calf serum (FCS) 10% v/v, penicillin 100 U/ml and streptomycin 100 U/ml. BTC had a passage level of 34. Each well of a 24-well plate (Linbro, Flow Laboratories) was seeded with . 1.6 X lo5 cells, incubated at 37°C with C02 5% in air for 5 days at which time confluency had been reached. The cells were washed once with phosphate-buffered saline (PBS: pH 7.4, free of calcium and magnesium ions) and the cells in each well were overlaid with 0.5 ml of antibiotic-free BME/H containing FCS 4% v/v and agarose (Seaplaque, Marine Colloids) 2% w/v. The agarose top layer was allowed to solidify at room temperature for 10 min before each P multocida isolate was inoculated on to half of the agarose surface of each well. A toxigenic strain of P multocida was always included in each test run. Plates were incubated at 37°C and C02 5% in air for 72 h before observation. The presence of toxin was confirmed by observing the morphology of BTC through an inverted microscope (25 X magnification). Typically, cytotoxin-producing strains induced BTC to appear more granular and rounded compared with non-toxigenic isolates of P multocida [2] . Isolates were tested in triplicate wells for each treatment and examined for cytotoxicity after incubation for 18, 24, 48 and 72 h.
Extraction of genomic DNA with 5 ml of sterile PBS and cells were gently removed by scraping with a glass L-shaped rod. The resuspended bacteria were pelleted by centrifugation and washed three times with PBS. DNA was extracted essentially as described previously [25, 26] . Briefly, the bacterial pellets were resuspended in 4 ml of TE buffer (10 mM Tris-HC1, 1 mM EDTA, pH 7.4) containing sucrose 10%. Lysozyme (50 mg) was added and the mixture was incubated at room temperature (RT) for 10 rnin before the addition of 50 pl of SDS 10% and 30 pl of RNAase A (10 rng/ml), then incubated at 37°C for 1 h before proteinase K (500 pg) was added. The resultant mixture was incubated at 37°C for 2 h followed by incubation at 56°C Overnight. This mixture was then extracted three times with pheno1:chloroform: isoarnyl alcohol (2524: 1) and once with chloroform: isoamyl alcohol in serum separator tubes (Becton Dickenson). Finally, the aqueous phase containing the DNA was dialysed overnight with three changes of TES buffer (TES: 10 mM Tris HCl, pH 7.4, 1 mM EDTA, 100 mM NaCl). The concentration and purity of DNA were determined spectrophotornetrically. Although large amounts of DNA (3-5 rng) were readily recovered by the above protocol, this study was unable to P multocida isolates were grown overnight on blood reliably generate clear CfoI restriction profiles with agar (3 X 90 rnm plates/isolate) which were flooded DNA recovered from toxigenic, capsular type D
isolates. An alternate DNA extraction protocol based on hexadecyltrimethylammonium bromide (CTAB) was used to extract whole-cell DNA from these isolates. Briefly, 200 mg of bacterial pellet were resuspended in 2 ml of TSK (TSK: 10 mM Tris-HC1, pH 8.0, 1 mM E,DTA, SDS 0.5% and proteinase K 200 pg) and incubated at 37°C for 1 h. A 280-pl volume of 5 M NaCl was added followed by 200 p l of CTAB solution (CTAB: hexadecyltrimethylammonium bromide 10% w/v in 0.3 M NaC1). After mixing by inversion, the DNA lysate was incubated for 10min at 65°C. DNA was purified by pheno1:chloroform: isoamyl alcohol extraction as described above.
Southern hybridisation
Plasmid pPMF3.5 (kindly supplied by Dr E. M. Kamp, Department of Bacteriology, Central Veterinary Institute, Lelystad, The Netherlands) was transformed into E'. coli strain DHSa, cultured on LB medium containing carbenicillin 50 pg/ml overnight with shaking and pelleted by centrifugation (5000 rpm, SS34 head). Plasmid DNA was extracted by column chromatography according to the manufacturer's instructions (Qiagen, Hilden, Germany). pPMF3.5 which contains the 3' half of the toxA gene was mapped with the restriction endonucleases EcoRI, Xba I, HindIII and combinations thereof to confirm the identity of the plasmid construct [4] . pPMF3.5 and lambda DNA digested with HindIII were labelled with 32P with an Amersham random priming kit (Amersham). P multocida genomic DNA digested with CfoI was resolved in agarose 1 .O% gels, transferred to nylon membrane, cross-linked with ultraviolet light and hybridised with radiolabelled pPMF3.5 [27] . The nylon membrane was washed three times under stringent temperature and salt conditions (65"C, 2 X SSC) and exposed to film (Fuji RX, Japan) at -80°C for 1-3 days.
Polyacrylamide gel electrophoresis
I? multocida whole-cell DNA (1 -2 pg) digested with the restriction endonuclease CfoI was loaded on to polyacrylamide 3.5% gels (12 X 16 cm) and immediately pulsed into the gel matrix at 80 V for 10 min. The gels were electrophoresed overnight (1 7-19 h, 35 V/gel) in TBE buffer (TBE: 90mM Tris-HCl, 90 mM borate, 2 mM EDTA) with a Hoefer maxi gel apparatus as described previously [25] . The gels were removed, washed once with milliQ water and stained with silver as described by the manufacturer (Rapid Silver Stain, INC Biomedical). Gels were fixed in acetic acid 0.1% and photographed immediately.
Polymerase chain reaction
Primers which amplify a 1.2-kb fragment of the toxA gene of P multocida [18] were used to confirm the presence of the toxA gene. Primer sequences were as follows: primer 1 , 5 '-TACTCAATTGAAAAAGCGC TTTATCTTCC-3' and primer 2, 5'-TCTACTACAGTT GCTGGTATTTTTAAATAT-3 ' . PCR amplification conditions were similar to those described by Nagai et al. [18] and consisted of the following: 1 ,UM of each oligonucleotide primer, 200 PM of each nucleotide triphosphate, 2.5 U of Taq polymerase (Stoffle enzyme), 1 X reaction buffer (10 mM Tris-HC1, pH 8.3, 10 mM KC1) and sample DNA (100 ng) in a final volume of 50 pl. The reaction mixture was subjected to an amplification regimen consisting of an initial denaturation step (95"C, 2 min) followed by 25 cycles of 92°C (1 min), 55°C (1 min) and 70°C (2 min) with a Corbett Research FTS 960 thermocycler. A portion of the reaction mixture (1 5 pl) was electrophoresed through agarose 1.0% gel with 0.5 X TBE buffer, 60 V for 1.5 h. The PCR amplification product was visualised with ethidium bromide and photographed with Polaroid 667 film. The presence of the toxA gene amongst the 22 isolates of P multocida was examined by Southern hybridisation and PCR analyses of purified DNA. Southern blotting of the CfoI-digested whole-cell DNA from P multocida when probed with 32P-labelled pPmF3.5, confirmed that the 10 pneumonic isolates did not possess the toxA gene. Nasal swab isolates 2, 3 and 8 also did not hybridise with 32P-labelled pPmF3.5. However, Cfo I-digested whole-cell DNA from toxigenic isolates 15-21 showed the presence of three strongly hybridising fragments of c. 3.9, 1.9 and a PCR primers [18] facilitated the amplification of a 1.2-kb fragment of the toxA gene from whole-cell DNA purified from isolates 1 and 15-22. DNA from isolates of P multucida which were not toxigenic in the agarose gel overlay assay (isolates 2-14) and which did not hybridise with pPmF3.5 (data not shown) also failed to show any amplification product in the PCR (Table 1) .
Results
Capsular typing of porcine P multocida isolates
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Genomic characterisation
Isolates from nasal swabs. Isolates 15-2 1 were obtained during sporadic outbreaks of progressive atrophic rhinitis in pig herds at different geographic localities in NSW (Fig. 2a) . DNA from these seven isolates displayed remarkably similar Cfo I restriction endonuclease profiles (Fig. 2a) . Apart from a single, darkly stained fragment with a molecular size of c. 4.6 kb (arrowhead, lane 5), the CfoI-generated restriction endonuclease profiles of these seven isolates were indistinguishable. The CfoI DNA profile of isolate 8 (non-toxigenic, capsular type D) was clearly different from the typical CfoI profile of toxigenic capsular type D isolates (Fig. 2b) (Fig. 3) .
Pneumonic isolates.
Restriction endonuclease analysis (with CfoI) of DNA purified from whole-cell lysates of pneumonic P multocida isolates 4, 5, 6, 7, 9, 10, 11, 12, 13 and 14, irrespective of capsular type, revealed considerable heterogeneity (Figs. 3 and 4) . Isolates 4, 5 and 6, all from pigs in herds located near Munvillumbah, NSW, generated readily discernible Cfu I profiles compared with one another and with all other isolates (Figs. 3 and 4) . CfoI profiles of DNA from isolates 7 and 10 were virtually indistinguishable from one another (except for a single fragment c. 6.7 kb in size, identified with an arrowhead), indicating a close genetic relationship (Fig. 4, lanes 5 and 6) . CfoI profiles of DNA from isolates 9 (Condobolin, NSW) and 11 were readily discernible from one another and from all other isolates. DNA from isolate 14 (Joadja, NSW) also generated a unique CfoI profile (Fig. 4) .
Isolates 5 (Munvillumbah, NSW) and 11, both capsular type A, non-toxigenic isolates, displayed similar CfoI DNA profiles, although each could be easily distinguished from the other by the presence of high mol. wt fragments (Fig. 3) 12 (Wannamal, WA) and 13 (Katanning, WA) were from farms separated by c. 320 km. CfoI-generated DNA profiles of these two isolates were similar, although at least six fragments were different (Fig. 4) . Isolate 2, cultured from a nasal swab from a pig in Byford, WA, also possessed a non-toxigenic, capsular type A phenotype. Byford is c. 95 km from Wannamal. The CfoI profiles of DNA from isolates 2 and either 12 or 13 were dissimilar (Fig. 4) .
Discussion
Capsular types A and D of I? multocida are economically significant pathogens of commercial pig industries because of their ability to induce PAR and their involvement in pneumonia as secondary invaders that exacerbate lung pathology initiated by primary colonising agents. There have been no reports comparing the genomic profiles generated by REA of isolates from the nasal mucosa and lung lesions of pigs with clinical symptoms of PAR and pneumonia respectively. Although this study compared restriction endonuclease profiles from only a limited number of isolates of I? multocida, their origin from lung lesions in sporadic outbreaks of pneumonia and from nasal swabs of pigs in herds displaying symptoms of PAR from different states across Australia sheds light on the degree of genomic heterogeneity inherent in this species. A comparison of the CfoI profiles of genomic DNA purified from eight toxigenic type D isolates of P multocida from two geographically distant states (WA and NSW) showed remarkable similarities. The enhanced resolution of the CfoI profiles afforded by 1 2 3 4 5 6 7 8 9
. . kb -9.4 -6.6 -4.4 -2.2 -2.0 Fig. 3 . Silver-stained polyacrylamide 3.5% gel showing Cfo I restriction endonuclease profiles of whole-cell DNA from toxigenic and non-toxigenic porcine isolates of P multocida. Lane 1, toxigenic, capsular type A isolate 22 (Cootamundra, NSW) from a nasal swab; 2, isolate 18 (Galore, NSW); 3, isolate 19 (Deniliquin, NSW); 4, toxigenic isolate 1 (Byford, WA); 5 , isolate 11 from a pneumonic lesion; 6 , isolate 5 (Murwillumbah, NSW) from a pneumonic lesion; 7, isolate 14 (Joadja, NSW) from a pneumonic lesion; 8, isolate 6 (Murwillumbah, NSW) from a pneumonic lesion; 9, isolate 9 (Condobolin, NSW) from a pneumonic lesion. Molecular mass markers correspond to lambda DNA digested with Hind111 (sizes in kb).
polyacrylamide gel electrophoresis and silver staining showed that these eight isolates were clonal. These observations confirm the hypothesis that outbreaks of PAR since 1985 in Australia were initiated from a common infectious source comprising a toxigenic capsular type D strain of I? multocida as suggested by Gardner et al. [22] . Mercy et al. [9] described the first outbreak of PAR in WA after the importation of two sows and it was believed that spread was limited to other states [22] . According to Gardner et al. [22] , a second outbreak in South Australia (SA) and the associated sale of breeding pigs from this herd to c. Although P multocida has been recognised as an important pathogen in the development of PAR, its role in the aetiology of swine pneumonia is unclear. It is generally considered that P multocida is not a primary colonising agent of the swine respiratory tract and initial infection with Mycoplama hyopneumoniae [30, 31] or one of several viruses including adenovirus [32] , hog cholera virus [33] Further studies are required to determine the degree of genetic heterogeneity amongst a larger number of isolates of R mziltocida associated with pneumonia. Finally, polyacrylamide gel electrophoresis and silver staining produce highly informative DNA fingerprints which should be useful in studies tracing outbreaks of PAR and pneumonia in swine.
